MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
(note 4)
$506,839K
Cash and cash
equivalents
$144,090K
Prepaid expenses and
other current assets
$26,503K
Total property and
equipment
$65,674K
Marketable securities,
non-current (note 4)
$894,724K
Total current assets
$677,432K
Right-of-use assets,
operating leases
$41,736K
Property and equipment,
net (note 6)
$41,617K
Other non-current
assets
$7,697K
Restricted cash
$5,810K
Less accumulated
depreciation
$24,057K
Total assets
$1,669,016K
Total liabilities and
stockholders equity
$1,669,016K
Total stockholders
equity
$1,539,637K
Total liabilities
$129,379K
Accumulated deficit
-$1,135,195K
Accumulated other
comprehensive loss
-$4,194K
Additional paid-in capital
$2,679,018K
Operating lease
liabilities, net of current...
$65,585K
Total current
liabilities
$62,643K
Finance lease
liabilities, net of current...
$1,151K
Common stock, 0.0001
par value...
$8K
Accrued expenses (note
8)
$35,095K
Accounts payable
$12,839K
Operating lease
liabilities
$12,032K
Finance lease
liabilities
$1,701K
Other current
liabilities
$976K
Back
Back
Balance Sheet
source: myfinsight.com
Kymera Therapeutics, Inc. (KYMR)
Kymera Therapeutics, Inc. (KYMR)